Show notes
The life sciences industry has long justified slow digital adoption through regulation. But as technology adoption accelerates faster than guidance, that logic is breaking down.
In this episode, Michelle Vuolo and Gilad Langer discuss why speed has become a defining challenge for pharma and medical device manufacturers. Drawing on experience from ISPE, quality leadership, and decades in regulated operations, they explore validation 4.0, cultural resistance to risk-based thinking, and how AI is reshaping quality and compliance work.
The conversation examines what it really takes for life…
Website: augmentedpodcast.co

